Compare Charles River Laboratories Intl. Inc (CRL) vs Shell PLC (SHEL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs Shell PLC — how do they compare? Charles River Laboratories Intl. Inc trades at $301.79 (market cap $14.23B), while Shell PLC trades at $100.18 (market cap $284.34B). The key difference: Shell PLC is far larger — about 20× Charles River Laboratories Intl. Inc's market cap, and Shell PLC pays a 3.12% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and Shell PLC for 90 Days on average.
| CRL | SHEL | |
|---|---|---|
Market Cap | $14.23B | $284.34B |
Volume | 1,176,885 | 9,097,469 |
Sector | Health | Energy |
52-Week High | $310.77 | $100.20 |
52-Week Low | $149.93 | $70.31 |
Typical Hold Time | 33 Days | 90 Days |
Enterprise Value | $17.06B | $326.04B |
Dividend Yield | — | 3.12% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $298, down 0.77% on the day, with strong analyst support showing 73% buy ratings and a $305.50 consensus price target. The stock maintains a bullish technical outlook with support at $292 and resistance at $301, while recent earnings have consistently beaten expectations despite negative net income margins. The company's 2026 Investor Day highlighted a strategic vision targeting 5-7% organic growth and $300 million in savings by 2030.
CRL presents a compelling growth story with solid operational cash flow and strategic initiatives, though investors face risks from negative profitability metrics and elevated valuation multiples. The stock's current position near analyst targets suggests limited upside without improved earnings execution, while ongoing margin pressures and debt levels require careful monitoring amid the company's transformation efforts.
Shell (SHEL) trades at $100.20, up 3.46% today, approaching its 52-week high. The stock shows strong technical momentum with bullish moving averages and positive earnings surprises in recent quarters. Recent developments include the approval of LNG Canada Phase 2 expansion, doubling export capacity, and strategic portfolio optimization through asset sales. Financial metrics indicate solid profitability with 8.76% net income margin and attractive valuation at P/E of 11.08.
Shell presents a compelling investment case with strong LNG growth prospects and portfolio optimization driving future cash flows. However, declining revenue trends from $381.3B in 2022 to $266.9B in 2025 and volatile energy prices pose execution risks. Analyst consensus remains bullish with $102.53 price target, though current RSI levels suggest potential near-term overbought conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About Shell PLC
Shell is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.7 million barrels of liquids and 8.7 billion cubic feet of natural gas per day. At year-end 2021, reserves stood at 9.2 billion barrels of oil equivalent, 50% of which consisted of liquids. Its production and reserves are in Europe, Asia, Oceania, Africa, and North and South America. The company operates refineries with capacity of 1.8 mmb/d located in the Americas, Asia, Africa, and Europe and sells 15 mtpa of chemicals. Its largest chemical plants, often integrated with its local refineries, are in Central Europe, China, Singapore, and North America.
Read more on SHEL →
